[thTED THIS 6 Between FAVORABLE FORT LIMITED andRDLIFE SERVICES (S)E. _______________________________________ SHARES PURCHASEREEMENT relating to the purchase of 1,700 ordinary shares in FAVORABLE FORT LIMITED _______________________________________ TABLE OFNTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 1 2.LE AND PURCHASE OF THE REPURCHASED SHARES 5]
[thTED THIS 6 Between FAVORABLE FORT LIMITED andRDLIFE SERVICES (S)E. _______________________________________ SHARES PURCHASEREEMENT relating to the purchase of 1,700 ordinary shares in FAVORABLE FORT LIMITED _______________________________________ TABLE OFNTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 1 2.LE AND PURCHASE OF THE REPURCHASED SHARES 5]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013 2Q13 New Subscribers Up 33.0% to 18,491 2Q13 Revenue Up 30.5% YOY to RMB128.5 Million 2Q13 Operating Income Up 24.7% to RMB47.0 Million Conference Call to be Held November 20, 2012 at 8:00 a.m. ET HONG KONG, China, November 19, 2012 — China]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013 2Q13 New Subscribers Up 33.0% to 18,491 2Q13 Revenue Up 30.5% YOY to RMB128.5 Million 2Q13 Operating Income Up 24.7% to RMB47.0 Million Conference Call to be Held November 20, 2012 at 8:00 a.m. ET HONG KONG, China, November 19, 2012 — China]
[SCHEDULE 13D (Amendment No. ____)* China Cord Blood Corporation (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) Jeremy Pinh Yee Cordlife Group Limited 61 Science Park Road, #05-16/18 The Galen Singapore Science Park II, Singapore 117525 Telephone: +65 6238-0808 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]
[SCHEDULE 13D (Amendment No. ____)* China Cord Blood Corporation (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) Jeremy Pinh Yee Cordlife Group Limited 61 Science Park Road, #05-16/18 The Galen Singapore Science Park II, Singapore 117525 Telephone: +65 6238-0808 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]
[Chinard Bloodrporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013 2Q13 New Subscribers Up 33.0% to 18,491 2Q13 Revenue Up 30.5% YOY to RMB128.5 Million 2Q13 Operatingome Up 24.7% to RMB47.0 Millionnferencell to be Held November 20, 2012 at 8:00 a.m. ET]
[SCHEDULE 13D (Amendment No. ____)* Chinard Bloodrporation (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) Jeremy Pinh Yeerdlife Limited 61ience Park Road, #05-16/18 The Galen Singaporeience Park II, Singapore 117525 Telephone: +65 6238-0808 (Name,dress and Telephone Number of Person Authorized]
[SCHEDULE 13D (Amendment No. ____)* Chinard Bloodrporation (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) Jeremy Pinh Yeerdlife Limited 61ience Park Road, #05-16/18 The Galen Singaporeience Park II, Singapore 117525 Telephone: +65 6238-0808 (Name,dress and Telephone Number of Person Authorized]
[Strictly Confidential Execution Copy REGISTRATION RIGHTS AGREEMENT between CHINA CORD BLOOD CORPORATION and CORDLIFE GROUP LIMITED Dated November 12, 2012 TABLE OF CONTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THIS AGREEMENT 5 Section 3 MANDATORY REGISTRATION 5 Section 4 DEMAND REGISTRATION RIGHTS 8 Section 5 INCIDENTAL OR “PIGGY-BACK” REGISTRATION 9 Section 6 UNDERWRITTEN OFFERINGS 10] [Strictly Confidential Execution Copy DIRECTOR INDEMNIFICATION AGREEMENT between CHINA CORD BLOOD CORPORATION and Jeremy Pinh Yee Dated November 12, 2012 TABLE OF CONTENTS Contents Page 1. Interpretation 1 2. Indemnity 3 3. Limitations on Indemnity 4 4. Company’s Liability 4 5. 5 6. Advancement of Expenses 5 7. Notification and Conduct of Claims 6 8. Directors’ and Officers’ Liability Insurance] [China Cord Blood Corporation Announces Completion of Strategic HONG KONG, China, November 12, 2012 As a result of the transaction, CCBC now wholly owns the equity ownership of Guangzhou Municipality Tianhe Nuoya Bio-engineering Co. Ltd. (“Nuoya”), the Company’s operating arm in Guangdong province, and Cordlife acquired 7,314,015 ordinary shares of the Company, representing approximately 10% of the Company’s issued and]
